Related Experiment Video
Updated: Jan 28, 2026

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
Published on: February 22, 2019
SMAC mimetics as potential cancer therapeutics in myeloid malignancies
Prajwal Boddu1, Bing Z Carter2, Srdan Verstovsek2
1Department of Hematology and Oncology, Yale University School of Medicine, New Haven, CT, USA.
Abstract:
Evasion of apoptosis has been identified as one of the essential hallmarks of cancer. Inhibitor of apoptosis proteins (IAPs) are implicated in a host of myeloid malignancies, providing the rationale for strategies aimed at neutralizing IAPs to lower the cancer cell apoptosis threshold. Modes of IAP antagonism may include down-regulating IAP expression, up-regulating endogenous pro-apoptotic proteins, such as tumour necrosis factor-α or Fas ligand, or directly antagonizing IAP activity against caspases. Direct targeting of IAPs using mimetics of the second mitochondria-derived activator of caspase (SMAC) protein has shown therapeutic promise by sensitizing the effect of chemotherapy on malignant cells. In pre-clinical studies, SMAC mimetics have demonstrated broad synergistic activity with a wide range of therapeutics, including cytotoxic chemotherapy, receptor tyrosine kinase inhibitors, agents targeting death receptors and alternative mechanisms of cell death, such as necroptosis or autophagy and immune check point blockade. SMAC mimetics represent a novel approach for further investigation in patients with high-risk, chemo-refractory blood cancers, as single agents or in thoughtfully selected combinations. In this review, we discuss the development and therapeutic rationale of small molecule SMAC mimetics, with an emphasis on agents in clinical development for myeloid malignancies.
Insights
Small molecule SMAC mimetics offer a novel therapeutic strategy for myeloid malignancies by sensitizing cancer cells to apoptosis. These agents show promise in pre-clinical studies, particularly for high-risk, chemo-refractory blood cancers.
Area of Science:
- Oncology
- Molecular Biology
- Drug Development
Background:
- Evasion of apoptosis is a key hallmark of cancer, with Inhibitor of Apoptosis Proteins (IAPs) playing a significant role in myeloid malignancies.
- Targeting IAPs is a rational strategy to lower the cancer cell apoptosis threshold and enhance treatment efficacy.
Purpose of the Study:
- To review the development and therapeutic rationale of small molecule second mitochondria-derived activator of caspase (SMAC) mimetics.
- To emphasize SMAC mimetics in clinical development for myeloid malignancies.
Main Methods:
- Discussing various modes of IAP antagonism, including expression modulation and direct caspase antagonism.
- Highlighting the use of SMAC mimetics to directly antagonize IAP activity against caspases.
- Reviewing pre-clinical data on SMAC mimetic synergy with diverse therapeutic agents.
Main Results:
- SMAC mimetics have shown therapeutic promise by sensitizing malignant cells to chemotherapy.
- Pre-clinical studies demonstrate broad synergistic activity of SMAC mimetics with cytotoxic chemotherapy, TKIs, death receptor agents, and immune checkpoint inhibitors.
- SMAC mimetics also show synergy with alternative cell death mechanisms like necroptosis and autophagy.
Conclusions:
- SMAC mimetics represent a novel therapeutic approach for high-risk, chemo-refractory blood cancers.
- Further investigation of SMAC mimetics as single agents or in combination therapies is warranted.
- This review focuses on the clinical development of small molecule SMAC mimetics for myeloid malignancies.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
09:18TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents
Published on: June 2, 2016
Related Concept Videos
Therapeutic Index
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Standard Electrode Potentials
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
The Resting Membrane Potential